CommerceHub Announces Third Quarter 2017 Financial Results
Nov 08, 2017 21:01 pm UTC| Business
Revenue of $24.6 million increased 10% Year-Over-Year, $0.04 GAAP EPS, $0.08 adjusted EPSSigned new drop-ship agreement with top 10 U.S. retailer in grocery and general merchandise vertical Signed a top 10 Canadian...
MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results
Nov 08, 2017 21:01 pm UTC| Business
ROCKVILLE, Md., Nov. 08, 2017 -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...
Collegium Reports Third Quarter Financial Results and Provides Corporate Update
Nov 08, 2017 21:01 pm UTC| Business
Xtampza® ER prescriptions grow by 49% in the third quarterFDA Approval of sNDA, including Comparative OxyContin DataStrong balance sheet provides cash runway into mid-2019 Conference call scheduled for today at 4:30 p.m....
Xenon Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
Nov 08, 2017 21:01 pm UTC| Business
BURNABY, British Columbia, Nov. 08, 2017 -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's President and Chief Executive Officer,...
NV5 Announces Strong Third Quarter and Year-to-Date 2017 Financial Results; Raises EPS Guidance
Nov 08, 2017 21:01 pm UTC| Business
HOLLYWOOD, Fla., Nov. 08, 2017 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, today reported financial results for the third...
Rockwell Medical Reports Third Quarter Results
Nov 08, 2017 21:01 pm UTC| Business
Conference Call and Webcast Today at 4:30 p.m. EST. WIXOM, Mich., Nov. 08, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), reported results for the three and nine months ended Sept. 30, 2017. Q3 2017 Financial...
Achaogen Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 08, 2017 21:01 pm UTC| Business
-- Plazomicin New Drug Application (NDA) submitted to the U.S. Food and Drug Administration (FDA) for the treatment of complicated urinary tract infections (cUTI) and bloodstream infections (BSI) -- -- C-Scape, an...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update